Fungal Frontiers: Navigating Implantation Mycoses and Vulvovaginal Candidiasis | October 16, 2025
Date of Presentation: October 16, 2025
Type: Past Presentation
Audience: Clinical
Program: Infectious Disease
Keywords: #avian #covid #fungal #hiv prep #implantation mycoses #infectious diseases #influenza #measles #vulvovaginal candidiasis
In this series of presentations, Dr. Jon Iralu, provides an overall infectious disease clinical update focusing on COVID-19, avian influenza, measles, and HIV PrEP. Then, Dr. Dallas Smith reviews the epidemiology, diagnosis, and treatment of Implantation Mycoses and Vulvovaginal Candidiasis through case studies and recent analyses using Indian Health Service data.
Recording:
Presented by:
Dallas Smith
PharmD
Dr. Dallas Smith, PharmD, is an epidemiologist with the Mycotic Diseases Branch in the National Center for Zoonotic and Emerging Infectious Diseases at the Centers for Disease Control and Prevention. He is a pharmacist by training, and his main research interests include dimorphic fungal diseases, fungal neglected tropical diseases, and antifungal stewardship.
Dr. Jon Iralu
Faculty
Dr. Iralu, MD, MACP, FISDA, is the Indian Health Service Chief Clinical Consultant for Infectious Diseases. He has a special interest in HIV, tuberculosis, and sexually transmitted disease care in rural communities. His research has focused on undifferentiated febrile illness in the American Southwest and on rural HIV care delivery. He has worked at Gallup Indian Medical Center since 1994 and is an instructor at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital Division of Global Health Equity in Boston, Massachusetts.
Read the full bio …
Dr. Jorge Mera
Faculty
Dr. Jorge Mera is the director of the Infectious Disease Department at the Cherokee Nation Health Services, the largest tribally operated health care system in the United States. In 2014, in response the HCV national epidemic he launched the first ProjectECHO hub in the state of Oklahoma. This hub was focused on Hepatitis C treatment and elimination and has provided treatment recommendations to over 1400 American Indian/Alaska Native patients with HCV. In addition, Dr. Mera has been instrumental in the implementation of other ECHO hubs across Indian Country. These hubs have focused on COVID-19, HIV, HIV PrEP, infectious diseases, substance use disorders and eliminating the HIV/HCV/SUD/Syphilis syndemic. Dr. Mera completed his fellowship in Infectious Diseases and Clinical Microbiology at Baylor College of Medicine in Houston, Texas and is Board Certified by the American Board of Internal Medicine in Infectious Diseases. He is an Associate Professor in the Infectious Diseases Division at the University of New Mexico, Health Science Center, Strategic Advisor for Project ECHO in Latin America, as well as the ECHO Medical Director for the Northwest Portland Area Indian Health Board. Dr. Mera is a Fellow of the American College of Physicians.
Read the full bio …Resources Provided:
- Infectious Disease Update (Presentation Slides)
- Fungal Frontiers: Navigating Implantation Mycoses and Vulvovaginal Candidiasis (Presentation Slides)
Date added: October 16, 2025











































